<?xml version='1.0' encoding='UTF-8' standalone='no'?>
<!DOCTYPE topic PUBLIC "-//OASIS//DTD DITA Topic//EN" "topic.dtd">
<topic id='business_definition_international_neuroblastoma_risk_group_staging_system.description'>
  <title>Description</title>
  <titlealts>
    <searchtitle>NHS Business Definition: International Neuroblastoma Risk Group Staging System - Description</searchtitle>
  </titlealts>
  <body>
  <div>
    <p>
The 
              <xref outputclass="businessDefinition" keyref="business_definition_international_neuroblastoma_risk_group_staging_system">International Neuroblastoma Risk Group Staging System</xref>
 is a system for 
              <xref outputclass="class" keyref="class_cancer_staging">CANCER STAGING</xref>.        </p>
    <p>
The 
              <xref outputclass="businessDefinition" keyref="business_definition_international_neuroblastoma_risk_group_staging_system">International Neuroblastoma Risk Group Staging System</xref>
 (<xref outputclass="businessDefinition" keyref="business_definition_international_neuroblastoma_risk_group_staging_system">INRGSS</xref>) is a preoperative staging system.        </p>
    <p>
The extent of disease is determined by the presence or absence of image-defined risk factors (IDRFs) and/or metastatic 
              <xref outputclass="businessDefinition" keyref="business_definition_tumour">Tumour</xref>
 at the time of 
              <xref outputclass="class" keyref="class_patient_diagnosis">PATIENT DIAGNOSIS</xref>, before any treatment or surgery        </p>
    <p>
For further information on the 
              <xref outputclass="businessDefinition" keyref="business_definition_international_neuroblastoma_risk_group_staging_system">International Neuroblastoma Risk Group Staging System</xref>, see the 
              <xref href="https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#link/_834_toc" scope="external" format="html">National Cancer Institute website</xref>.        </p>
  </div>
</body>
</topic>